ENTITY
Giant Biogene

Giant Biogene (2367 HK)

167
Analysis
Consumer Staples • China
Giant Biogene designs, develops, manufactures, and sells beauty and health products, primarily functional skincare products and medical dressings, utilizing recombinant collagen as a key bioactive ingredient. The company also develops and manufactures functional foods based on rare ginsenosides technology. It was founded in 2000 and is headquartered in Xi'an, People's Republic of China.
more
bullish•Tencent
•07 May 2023 08:45

ECM Weekly (7th May 2023) - Mankind, Nexus REIT, Pertamina Hulu, Growatt, DXN, Giant Biogene, Ventia

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
563 Views
Share
•02 May 2023 16:46

HK Connect: Mar '22 Inclusion Post-Event Analysis

We analyzed the performance of stocks for the March 2023 batch of Hong Kong Connect inclusion, including the performance post announcement, post...

Logo
439 Views
Share
bearish•Giant Biogene
•02 May 2023 09:57

Giant Biogene IPO Lock-Up - US$1.7bn Lockup Release Will Increase Free Float by 14x

Giant Biogene raised around US$70m in its Hong Kong IPO, after having downsized the deal and priced it at the low-end. Its six-month lockup will...

Logo
686 Views
Share
bullish•ANTA Sports
•17 Apr 2023 20:39

Anta Sports Placement - A Large Deal to Digest with Unknown Use of Proceeds but Track Record Is Good

Anta Sports Products (2020 HK)  aims to raise around US$1.5bn in its top-up placement. In this note, we talk about the deal dynamics and run the...

Logo
1.1k Views
Share
bearish•Giant Biogene
•17 Mar 2023 08:55

Giant Biogene Holding (2367.HK) - The Situation May Not Be as Rosy as It Looks

After Giant Biogene has been added to Hong Kong Stock Connect, liquidity would improve a lot. But lower-than-expected market space, competition and...

Logo
612 Views
Share
x